Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Ver. Summary Created by Modification Content Size Created at Operation
1 + 451 word(s) 451 2020-12-15 07:23:22

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Yin, N. Factor X Deficiency. Encyclopedia. Available online: (accessed on 30 November 2023).
Yin N. Factor X Deficiency. Encyclopedia. Available at: Accessed November 30, 2023.
Yin, Nicole. "Factor X Deficiency" Encyclopedia, (accessed November 30, 2023).
Yin, N.(2020, December 25). Factor X Deficiency. In Encyclopedia.
Yin, Nicole. "Factor X Deficiency." Encyclopedia. Web. 25 December, 2020.
Factor X Deficiency

Factor X deficiency is a rare bleeding disorder that varies in severity among affected individuals. The signs and symptoms of this condition can begin at any age, although the most severe cases are apparent in childhood.

genetic conditions

1. Introduction

Factor X deficiency commonly causes nosebleeds, easy bruising, bleeding under the skin, bleeding of the gums, blood in the urine (hematuria), and prolonged or excessive bleeding following surgery or trauma. Women with factor X deficiency can have heavy or prolonged menstrual bleeding (menorrhagia) or excessive bleeding in childbirth, and may be at increased risk of pregnancy loss (miscarriage). Bleeding into joint spaces (hemarthrosis) occasionally occurs. Severely affected individuals have an increased risk of bleeding inside the skull (intracranial hemorrhage), in the lungs (pulmonary hemorrhage), or in the gastrointestinal tract, which can be life-threatening.

2. Frequency

Factor X deficiency occurs in approximately 1 per million individuals worldwide.

3. Causes

The inherited form of factor X deficiency, known as congenital factor X deficiency, is caused by mutations in the F10 gene, which provides instructions for making a protein called coagulation factor X. This protein plays a critical role in the coagulation system, which is a series of chemical reactions that forms blood clots in response to injury. Some F10 gene mutations that cause factor X deficiency reduce the amount of coagulation factor X in the bloodstream, resulting in a form of the disorder called type I. Other F10 gene mutations result in the production of a coagulation factor X protein with impaired function, leading to type II factor X deficiency. Reduced quantity or function of coagulation factor X prevents blood from clotting normally, causing episodes of abnormal bleeding that can be severe.

A non-inherited form of the disorder, called acquired factor X deficiency, is more common than the congenital form. Acquired factor X deficiency can be caused by other disorders such as severe liver disease or systemic amyloidosis, a condition involving the accumulation of abnormal proteins called amyloids. Acquired factor X deficiency can also be caused by certain drugs such as medicines that prevent clotting, or by a deficiency of vitamin K.

4. Inheritance

When this condition is caused by mutations in the F10 gene, it is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Acquired factor X deficiency is not inherited, and generally occurs in individuals with no history of the disorder in their family.

5. Other Names for This Condition

  • congenital Stuart factor deficiency
  • F10 deficiency
  • Stuart-Prower factor deficiency


  1. Brown DL, Kouides PA. Diagnosis and treatment of inherited factor Xdeficiency. Haemophilia. 2008 Nov;14(6):1176-82. doi:10.1111/j.1365-2516.2008.01856.x.
  2. Girolami A, Scarparo P, Scandellari R, Allemand E. Congenital factor Xdeficiencies with a defect only or predominantly in the extrinsic or in theintrinsic system: a critical evaluation. Am J Hematol. 2008 Aug;83(8):668-71.doi: 10.1002/ajh.21207. Review.
  3. Girolami A, Vettore S, Scarparo P, Lombardi AM. Persistent validity of aclassification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era. Haemophilia. 2011Jan;17(1):17-20. doi: 10.1111/j.1365-2516.2010.02328.x.
  4. Herrmann FH, Auerswald G, Ruiz-Saez A, Navarrete M, Pollmann H, Lopaciuk S,Batorova A, Wulff K; Greifswald Factor X Deficiency Study Group. Factor Xdeficiency: clinical manifestation of 102 subjects from Europe and Latin America with mutations in the factor 10 gene. Haemophilia. 2006 Sep;12(5):479-89.
  5. Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype andgenotype report on homozygous and heterozygous patients with congenital factor X deficiency. Haematologica. 2008 Jun;93(6):934-8. doi: 10.3324/haematol.12211.
  6. Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost. 2009Jun;35(4):407-15. doi: 10.1055/s-0029-1225763.
  7. Uprichard J, Perry DJ. Factor X deficiency. Blood Rev. 2002 Jun;16(2):97-110. Review.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 251
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 25 Dec 2020